美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

ArQule

20.00

0.0000

成交量：- -

成交额：- -

市值：24.17亿

市盈率：-58.12

高：20.00

开：20.00

低：20.00

收：20.00

数据加载中...

总览公司新闻公告

公司资料

公司名字：

ArQule

交易所：

NASDAQ

成立时间：

- -

员工人数：

- -

公司地址：

- -

官网：

http://www.arqule.com

邮编：

- -

电话：

- -

传真：

- -

简介：

<p>ARQULE公司是一家临床生物技术公司，从事癌症治疗的研究和药物开发。本公司产品是ARQ197，一种受体酪氨酸激酶口服抑制剂，用于癌症治疗。本公司对ARQ197进行商业使用认证，在美国，欧洲，南美和世界各地用于癌症治疗。</p>

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/ARQL/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ARQL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARQL\",,,,,undefined,":{"symbol":"ARQL","market":"US","secType":"STK","nameCN":"ArQule","latestPrice":20,"timestamp":1579122000000,"preClose":20,"halted":3,"volume":0,"delay":0,"floatShares":99121763,"shares":120873271,"eps":-0.344137,"marketStatus":"停牌","change":0,"latestTime":"05-20 12:14:54 EDT","open":20,"high":20,"low":20,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.344137,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1747771200000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":845438400000,"exchange":"NASDAQ","adjPreClose":20,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARQL\",,,,,undefined,":{"symbol":"ARQL","floatShares":99121763,"roa":"-16.32%","roe":"-32.12%","lyrEps":-0.156328,"shares":120873271,"dividePrice":0,"high":20,"amplitude":0,"preClose":20,"low":20,"week52Low":3.15,"pbRate":"15.79","week52High":20.45,"institutionHeld":0.8268,"latestPrice":20,"eps":-0.344137,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.344137,"open":20,"prevYearClose":19.96},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.arqule.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0203},{"period":"1month","weight":0.13},{"period":"3month","weight":-0.0272},{"period":"6month","weight":0.0074},{"period":"1year","weight":0.1235},{"period":"ytd","weight":0.015}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"<p>ARQULE公司是一家临床生物技术公司，从事癌症治疗的研究和药物开发。本公司产品是ARQ197，一种受体酪氨酸激酶口服抑制剂，用于癌症治疗。本公司对ARQ197进行商业使用认证，在美国，欧洲，南美和世界各地用于癌症治疗。</p>","exchange":"NASDAQ","name":"ArQule","nameEN":"Arqule"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"ARQL\",market:\"US\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ARQL\",params:#limit:5,,,undefined,":[{"date":"2019-10-30","symbol":"ARQL","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2019/09","expectedEps":-0.09,"defaultRemindTime":1572422400000,"name":null,"time":"盘前","dateTimestamp":1572408000000,"actualEps":null},{"date":"2019-08-07","symbol":"ARQL","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2019/06","expectedEps":-0.09,"defaultRemindTime":1565164800000,"name":null,"time":"盘前","dateTimestamp":1565150400000,"actualEps":0.05},{"market":"US","date":"2019-05-01","symbol":"ARQL","fiscalQuarterEnding":"2019/03","expectedEps":-0.08,"name":null,"time":"盘前","type":"earning","dateTimestamp":1556683200000,"reportTimeType":"pre","actualEps":-0.09},{"market":"US","date":"2019-03-07","symbol":"ARQL","fiscalQuarterEnding":"2018/12","expectedEps":-0.08,"name":null,"time":"盘前","type":"earning","dateTimestamp":1551934800000,"reportTimeType":"pre","actualEps":-0.08},{"market":"US","date":"2018-10-31","symbol":"ARQL","fiscalQuarterEnding":"2018/09","expectedEps":-0.06,"name":null,"time":"盘前","type":"earning","dateTimestamp":1540958400000,"reportTimeType":"pre","actualEps":-0.05}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ARQL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ARQL\",market:\"US\",delay:false,,,undefined,":{}}}